Biotinylation Reagent in Dimethylformamide; part

SECTION 2: Hazards identification

This material is considered hazardous by the OSHA Hazard Communication Standard ( 29 CFR 1910. 1200 ) Physical state Liquid. Odor Not available. OSHA/HCS status This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Emergency overview WARNING! CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION. MAY BE HARMFUL IF SWALLOWED. CONTAINS MATERIAL THAT CAN CAUSE TARGET ORGAN DAMAGE. BIRTH DEFECT HAZARD - CONTAINS MATERIAL WHICH CAN CAUSE BIRTH DEFECTS.

Precautionary statements

Do not handle until all safety precautions have been read and understood. Obtain special instructions before use. Do not breathe vapor or mist. Do not ingest. Use only with adequate ventilation. Do not eat, drink or smoke when using this product. Avoid contact with eyes, skin and clothing. Keep container tightly closed. Use personal protective equipment as required. Wash thoroughly after handling.

Potential Acute Health Effects

Eyes Irritating to eyes. Skin Irritating to skin. Inhalation Severely irritating to the respiratory system. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion Harmful if swallowed.

Potential chronic health

effects Contains material that can cause target organ damage. Carcinogenicity No known significant effects or critical hazards. Mutagenicity No known significant effects or critical hazards.

Teratogenic Effects

Contains material which can cause birth defects. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Target organs Contains material which may cause damage to the following organs: kidneys, liver, digestive system, cardiovascular system, upper respiratory tract, skin, eyes. Inhalation Adverse symptoms may include the following: respiratory tract irritation coughing reduced fetal weight increase in fetal deaths skeletal malformations Ingestion Adverse symptoms may include the following: reduced fetal weight increase in fetal deaths skeletal malformations Skin Adverse symptoms may include the following: irritation redness reduced fetal weight increase in fetal deaths skeletal malformations Eyes Adverse symptoms may include the following: pain or irritation watering redness reduced fetal weight increase in fetal deaths skeletal malformations

Medical Conditions Generally Aggravated by Exposure

Pre-existing disorders involving any target organs mentioned in this MSDS as being at risk may be over-exposure aggravated by over-exposure to this product. See toxicological information (Section 11)